How many people currently suffer from multiple sclerosis; whether all such patients will be given a neurological assessment to gauge their …

The Scottish Needs Assessment Programme (SNAP) report on multiple sclerosis estimates that around 10,400 people suffer from multiple sclerosis in Scotland. A copy of the SNAP report has been placed in the Parliament's Reference Centre (Bib. number 9354). A UK-wide risk-sharing scheme for the treatment of eligible patients with multiple sclerosis begins on 6 May 2002. The scheme allows beta interferon and glatiramer acetate to be prescribed on the NHS to patients who meet criteria set out by the Association of British Neurologists. Patients' eligibility for treatment will depend on the clinical judgement of the specialist neurologists concerned.The health departments do not underestimate the work required to set up and operate the scheme and will be holding regular meetings with professional and patient groups to assess progress. The scheme includes incentives for the pharmaceutical companies to increase their investment in generic specialist MS nursing services.Full details of the scheme are explained in Health Department Letter (2002) 6, a copy of which has been placed in the Parliament's Reference Centre (Bib. number 20653).